Acthar
Payments companies reported to CMS as associated with Acthar. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Acthar, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Acthar
These are the largest totals companies reported as associated with Acthar. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Peter Chang | Waltham, MA | Ophthalmology | $381,180.27 |
| Stephen Anesi | Waltham, MA | Ophthalmology | $378,865.48 |
| Paul Karpecki | Lexington, KY | Optometrist | $335,205.75 |
| Melissa Toyos | Memphis, TN | Ophthalmology | $330,283.56 |
| Steven Silverstein | Kansas City, MO | Ophthalmology | $329,795.44 |
| Kostas Botsoglou | Cheektowaga, NY | Rheumatology | $321,008.39 |
| John Affeldt | Loma Linda, CA | Ophthalmology | $300,596.62 |
| Raji Ayinla | Bronx, NY | Pulmonary Disease | $253,365.16 |
| Ara Dikranian | San Diego, CA | Rheumatology | $252,186.36 |
| Robert Baughman | Cincinnati, OH | Pulmonary Disease | $241,541.81 |
Prescribed Acthar?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.